- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
Détention brevets de la classe C12N 15/85
Brevets de cette classe: 11917
Historique des publications depuis 10 ans
|
630
|
766
|
1016
|
1021
|
895
|
1020
|
1052
|
1162
|
1081
|
634
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4698 |
399 |
| The Regents of the University of California | 20720 |
227 |
| Massachusetts Institute of Technology | 10239 |
164 |
| The Trustees of the University of Pennsylvania | 4414 |
146 |
| President and Fellows of Harvard College | 6091 |
142 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
111 |
| The Broad Institute, Inc. | 1975 |
103 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 229 |
68 |
| Sangamo Therapeutics, Inc. | 383 |
64 |
| Kymab Limited | 275 |
63 |
| The Johns Hopkins University | 5875 |
62 |
| Duke University | 3184 |
62 |
| The General Hospital Corporation | 4858 |
60 |
| Board of Regents, The University of Texas System | 6102 |
56 |
| Modernatx, Inc. | 1291 |
56 |
| University of Massachusetts | 2313 |
52 |
| Novartis AG | 10263 |
51 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
49 |
| Yale University | 2527 |
49 |
| The Board of Regents of the University of Texas System | 2294 |
44 |
| Autres propriétaires | 9889 |